Probiotics Simply Explained
Probiotics are live bacteria and yeasts taken via food or capsules. This page explains in simple terms what human studies show — and what remains open.
1. What It Is About
Probiotics are tiny living organisms: bacteria and yeasts. They remain alive when ingested. In sufficient quantities, they are intended to support health. Naturally, they occur in fermented foods such as yoghurt, kefir or sauerkraut (fermentation means that foods are preserved with the help of microorganisms). They are also found in capsules, powders and medicines.
The most common strains belong to the groups Lactobacillus and Bifidobacterium. A strain is a finely differentiated subgroup within a bacterial species. Yeasts such as Saccharomyces boulardii are also being studied.
For a probiotic to have an effect, it must survive the stomach, reach the intestine and remain there for a period of time. Important: not all probiotics are the same. Two closely related bacteria can have different effects. The strength of an effect depends on the strain, the quantity and the individual. Therefore, it cannot be said that 'probiotics work', but rather: this strain, in this group, over this period of time.
2. What Studies Show
The evaluation includes 4,112 works, including 747 controlled human studies. 'Controlled' means: one group receives the probiotic, another receives a sham treatment (placebo), and no one knows who receives what. The focus is on the gut and inflammation.
Irritable bowel syndrome: The review 2 summarises many controlled studies. Certain Lactobacillus and Bifidobacterium strains were able to alleviate symptoms. However, the results were not consistent — not every strain and not every study showed the same effect. This area is considered to have the best evidence.
Inflammation in diabetes and heart disease: In a controlled study 4, 60 people with diabetes and coronary heart disease received probiotics or a placebo for twelve weeks. In participants receiving probiotics, the inflammatory marker in the blood decreased more markedly than in the placebo group. This marker is called high-sensitivity CRP, a protein that rises during inflammation in the body. Fasting blood sugar and blood lipids were also measured. Limitation: only 60 people were involved, the duration was short, and the group was very specific.
Inflammation during pregnancy: In another controlled study 3, 60 women with gestational diabetes received probiotics or a placebo for six weeks. In the probiotic group, the inflammatory marker decreased, and a marker for cellular stress improved. Again, the group was small, and there was no follow-up observation.
After bowel cancer surgery: In a controlled study 1, 52 patients received a mixture of six bacterial strains or a placebo for six months after surgery for bowel cancer. Immune system messenger substances called cytokines were measured. The report omitted the numbers; a reduction in pro-inflammatory messenger substances was indicated. This is a hint, not proof.
Tolerability: Large safety studies show good tolerability 5. In people with weakened immune systems, however, infections caused by probiotics have been documented.
3. What Remains Unclear
Almost all controlled studies are small and short-term. Whether probiotics permanently alter the gut microbiota is unknown. Long-term studies lasting more than twelve months are still lacking, as are studies in healthy people.
It is also unclear whether an effect comes from a single strain or from the interaction of several. Many preparations contain multiple strains simultaneously. It is then no longer possible to determine which part had an effect.
How exactly the bacteria work is only partially understood. Studies mostly describe correlations, not causes. Whether results from animal experiments and cell cultures can be transferred to humans is uncertain, as the gut microbiota differs in every animal species and every human.
For people with weakened immune systems or premature infants, the balance between benefit and risk is unclear.
4. What This Means in Everyday Life
Probiotics are not a uniform product. The term only indicates that living microorganisms are contained — not which strain, in what quantity, or for whom. Two preparations with the same word on the label can be completely different in composition.
When reading a study, three things should be sought: which strain was studied? How long? On which group of people? Without this information, it is difficult to transfer a result to another situation.
In studies, probiotics were well tolerated by healthy people. In people with weakened immune systems, caution is advised, as infections have been documented.
What needs to be clarified next is whether individual strains can be specifically tested for certain conditions and whether an effect persists over months or years.
All details with study numbers and sources: detailed page on probiotics. For children: Probiotics for children.
Frequently Asked Questions
Are probiotics from the supermarket the same as those in studies?
Not necessarily. Studies test a precisely named strain in a precisely described amount. Supermarket products often list only the bacterial species, not the strain. Whether the same effect occurs cannot be concluded from this.
Can probiotics also be harmful?
In healthy people, studies reported good tolerability. In people with weakened immune systems, infections caused by probiotics have been documented. The assessment therefore does not apply equally to everyone.
Why are the results so different?
The gut microbiota varies from person to person. It depends on genes, diet, medications and lifestyle. This is why the same strain may have different effects in another group.
Do probiotics help with irritable bowel syndrome?
For the gut, the best evidence exists. Certain Lactobacillus and Bifidobacterium strains have been shown in studies to ease symptoms. However, results were not uniform, and not every strain showed the same effect.
Sources
- 1Zaharuddin L, Mokhtar NM, Muhammad Nawawi KN, Raja Ali RA · 2019
- 2Didari T, Mozaffari S, Nikfar S, Abdollahi M · 2015
- 3Badehnoosh B, Karamali M, Zarrati M, Jamilian M, Bahmani F, Tajabadi-Ebrahimi M et al. · 2018
- 4Raygan F, Rezavandi Z, Bahmani F, Ostadmohammadi V, Mansournia MA, Tajabadi-Ebrahimi M et al. · 2018
- 5Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR · 2009
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.